ABX
0.075
82.9%
AGN
0.28
-56.6%
KCCDA
1.04
55.2%
LML
0.006
-33.3%
4DX
1.155
50%
TMK
0.002
-33.3%
CTO
0.006
50%
1AD
0.003
-25%
M2R
0.003
50%
AYT
0.003
-25%
SNS
0.065
41.3%
SMM
0.012
-25%
8CO
0.04
33.3%
AX8
0.007
-22.2%
CTN
0.004
33.3%
ASP
0.008
-20%
MRQ
0.004
33.3%
BYH
0.004
-20%
TON
0.008
33.3%
COD
0.14
-17.6%
GIB
0.062
31.9%
ALM
0.005
-16.7%
CVB
0.14
27.3%
RLG
0.005
-16.7%
FLG
0.079
23.4%
EQR
0.035
-14.6%
ERL
0.006
20%
AKN
0.006
-14.3%
PGM
0.026
18.2%
COY
0.012
-14.3%
BUS
0.135
17.4%
MSG
0.006
-14.3%
TG1
0.034
17.2%
VML
0.185
-14%
ARV
0.007
16.7%
BMM
0.195
-13.3%
AZL
0.007
16.7%
GRE
0.052
-13.3%
BNL
0.007
16.7%
EQX
0.165
-13.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Memphasys (ASX: MEM): Accelerates FelixTM System

Reproductive biotechnology company Memphasys (ASX: MEM) has accelerated its FelixTM System sales orders in Japan, under its exclusive agreement with Vitrolife Japan KK, to sell and distribute the FelixTM System | ASX announcement: https://announcements.asx.com.au/asxpdf/20240318/pdf/061lr49l0r8k8h.pdf